Medical News

RSS

Treatment score aids decision-making in unruptured intracranial aneurysm management

Researchers have developed an unruptured intracranial aneurysm treatment score model that arms clinicians with consensus from a group of specialists on how to manage individuals with the condition.

20 Aug 2015

Failure To Rescue After Complications Defines Lung Cancer Resection Survival

The variation in mortality rates among patients undergoing lung cancer resection in US hospitals has been attributed by a cohort study to differences in failure-to-rescue rates after the development of complications.

20 Aug 2015

Low, moderate alcohol intake elevates women’s risk of alcohol-related cancers

Low to moderate alcohol consumption is linked to an increased risk of alcohol-related cancers in women, but not men, who have never smoked, research suggests.

20 Aug 2015

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Allergan plc, a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration has accepted the company's resubmission of its Supplemental Biologics License Application (sBLA) for BOTOX (onabotulinumtoxinA) for the treatment of adults with lower limb (involving ankle and toe muscles) spasticity in adults.

20 Aug 2015

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.

20 Aug 2015

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

20 Aug 2015

60P to commence Phase II clinical trial among dengue fever patients

60 Degrees Pharmaceuticals, a company focused on development of therapeutics for tropical diseases, and Singapore General Hospital announced today that the Hospital has received a grant from Singapore's National Medical Research Council to support a Phase II clinical trial among dengue fever patients.

20 Aug 2015

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells.

20 Aug 2015

AbVitro launches PairMe Grant Challenge to provide access to AbPair technology

AbVitro Inc., an immuno-oncology discovery company, today announced access to its AbPairTM technology by launching the "PairMe Grant Challenge."

20 Aug 2015

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company Specialised Therapeutics Australia Pty (STA) to market and distribute the drug candidate APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

First Virtual Support Network launched for women living with atrial fibrillation

WomenHeart: The National Coalition for Women with Heart Disease today announced the launch of the first Virtual Support Network specifically for women living with atrial fibrillation (afib) – a serious heart condition that carries a high risk of stroke.

20 Aug 2015

Stroke more likely if you work long hours, major study finds

People who work long hours are at a greater risk of stroke and coronary heart disease than people who work a standard week, according to the largest study of the issue to date, published in The Lancet.

20 Aug 2015

Surprising mechanism behind antibiotic resistant bacteria uncovered by TSRI scientists

Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.

20 Aug 2015

DelMar closes on $2.6 million registered direct placement

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced the closing of a registered direct placement (Placement) with $2.6 million received from the offering.

20 Aug 2015

Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that the United States Patent Office has granted U.S. patent no. 9,107,823 ('823 Patent) covering novel topical foam formulations that include dimethyl sulfoxide (DMSO) together with certain drug actives.

20 Aug 2015

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

Australian biopharmaceutical company Specialised Therapeutics Australia has struck an exclusive license and commercialisation agreement with European pharmaceutical partner company PharmaMar to market and distribute the novel oncology drug APLIDIN (plitidepsin) in Australia and New Zealand.

20 Aug 2015

CRY launches fundraising and awareness campaign 'Healthy Start'

In a small village in West Bengal, India, 7-month-old Anwesha is oblivious to the fact that in her community, for generations before her, many newborns did not even live to see their first birthday. In an age old tradition, the community believed that the survival of the newborn or the mother is pre-determined and no extra care or immunization should interfere with the inevitable. It was only after persistent effort by CRY-supported project SSDC for a decade that the attitude of the community began to change.

20 Aug 2015

Cyberonics, Sorin provide update on pending business combination

Cyberonics, Inc. and Sorin S.p.A. today announced an update on various matters relating to their pending business combination (the "Transaction").

20 Aug 2015

ArroHealth included in Inc. Magazine's list of fastest-growing private companies in the U.S.

ArroHealth, a full-service provider of risk adjustment and HEDIS services for health plans and provider groups, has been named to Inc. Magazine's 34th annual Inc. 5000, an exclusive ranking of the fastest-growing private companies in the U.S. ArroHealth's significant revenue growth over the past four years qualified it for the distinguished list.

20 Aug 2015

$IUPUI researcher receives NIH grant to study role of collagen in bone fracture resistance$

IUPUI researcher receives NIH grant to study role of collagen in bone fracture resistance

A biomedical engineer researcher at Indiana University-Purdue University Indianapolis has received a $419,000 National Institutes of Health grant to uncover why mechanical loading of bones increases their resistance to fractures.

20 Aug 2015

Medical News

Treatment score aids decision-making in unruptured intracranial aneurysm management

Failure To Rescue After Complications Defines Lung Cancer Resection Survival

Low, moderate alcohol intake elevates women’s risk of alcohol-related cancers

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

60P to commence Phase II clinical trial among dengue fever patients

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

AbVitro launches PairMe Grant Challenge to provide access to AbPair technology

PharmaMar to market and distribute APLIDIN drug candidate in Australia, New Zealand

First Virtual Support Network launched for women living with atrial fibrillation

Stroke more likely if you work long hours, major study finds

Surprising mechanism behind antibiotic resistant bacteria uncovered by TSRI scientists

DelMar closes on $2.6 million registered direct placement

Nuvo Research granted U.S. patent for novel topical foam formulations that use DMSO to enhance drug delivery

STA inks license and commercialisation agreement with PharmaMar for APLIDIN (plitidepsin)

CRY launches fundraising and awareness campaign 'Healthy Start'

Cyberonics, Sorin provide update on pending business combination

ArroHealth included in Inc. Magazine's list of fastest-growing private companies in the U.S.

IUPUI researcher receives NIH grant to study role of collagen in bone fracture resistance

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News